Clinical trials: CUP
Cancer of Unknown Primary Site
The NorCUP Trial: Improving Prognosis and Personalized Treatment in Cancer of Unknown Primary (CUP)
The goal of this clinical trial is to improve diagnosis and treatment strategies for patients with Cancer of Unknown Primary (CUP) by using advanced molecular profiling to identify the likely tumor origin and guide therapy.
- Trial name
- NorCUP (NCT07366008)
- Testing
- Comprehensive molecular profiling
- Where
- 6 sites in Norway
- Volunteers
- 350 people
- Sponsor
- Haukeland University Hospital
Natural Conception, Label Comprehension
FERTI-LILY Safety Study
The study is a prospective, 1-arm, open label, nonrandomized, single center study designed to evaluate label comprehension, device usability and safety of the FERTI·LILY Conception Cup.
- Conditions
- Natural Conception, Label Comprehension, Device Usability, Safety Issues
- Trial name
- NCT05529160
- Testing
- FERTI LILY Conception Cup
- Where
- United States
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- Rosesta Medical BV
Preterm, Feeding, Bottle
Comparison of Bottle and Cup Feeding on Transition to Full Breastfeeding and Discharge Time
Breastfeeding is the ideal feeding method and that in the absence of breastfeeding the bottle and cup feeding are common alternatives. There is a lack of evidence regarding superiority of either of these methods.
- Conditions
- Preterm, Feeding, Bottle, Feeding Behavior, Feeding, Breast
- Trial name
- NCT04975282
- Testing
- Bottle feeding, Cup feeding
- Where
- Turkey (Türkiye)
- Volunteers
- 158 people, healthy volunteers welcome
- Sponsor
- Pamukkale University
Menstrual Cup, Intrauterine Device Migration
Shifting of Intrauterine Device and Use of the Menstrual Cup: Case-control Study
In France, 26% of women of childbearing age use an intrauterine device (IUD) containing copper or levonorgestrel as a method of contraception. Failures of IUD contraception are mainly due to shifting or expulsion of the IUD.
- Trial name
- CUP-DIU (NCT04782583)
- Testing
- Questionnaire
- Where
- France
- Volunteers
- 740 people
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
Osteoarthritis, Hip, Osteonecrosis of Femoral Head
Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using Delta TT Cup
This study will evaluate clinical outcome on patients who undergo ceramic on ceramic (CoC) bearing total hip arthroplasty (THA) using Delta TT cup.
- Conditions
- Osteoarthritis, Hip, Osteonecrosis of Femoral Head, Femoral Neck Fractures, Rheumatoid Arthritis of Hip
- Trial name
- NCT04594564
- Testing
- Total hip arthroplasty with Delta TT cup
- Where
- South Korea
- Volunteers
- 270 people
- Sponsor
- Seoul National University Hospital
Osteoarthritis of the Hip
Validity, Reliability and Reproducibility of Plain Radiographic Measurements After Total Hip Arthroplasty
In total hip arthroplasty (THA), radiographic preoperative planning and postoperative evaluation of acetabular component, femoral offset (FO) and leg length discrepancy (LLD) require good validity, interobserver reliability and…
- Trial name
- NCT02102334
- Where
- Sweden
- Volunteers
- 90 people
- Sponsor
- Sundsvall Hospital
Cancer
Hybrid PET/CT in Cancer Patients
The purpose of the present study is to assess the role of hybrid PET/CT imaging diagnosis of active malignancy in cancer patients with rising tumor markers after treatment and in the diagnosis of primary tumor in patients with…
- Trial name
- NCT00396916
- Testing
- PET/CT imaging
- Where
- Israel
- Volunteers
- 45 people
- Sponsor
- Rambam Health Care Campus
Androgenetic Alopecia
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia
The primary purpose of this study is to assess the safety of performing injections of human autologous hair follicle cells. The study will also measure the impact these injections will have on hair growth.
- Trial name
- NCT01286649
- Testing
- Human autologous hair follicle cells, Cell medium
- Where
- Georgia
- Volunteers
- 19 people
- Sponsor
- TrichoScience Innovations, Inc.
Radiostereometric Analysis, Vitamin E Liner
A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene
The purpose of this study is to use Radiostereometric Analysis (RSA) and clinical outcome measures to evaluate early, post-operative implant stability, post-operative implant fixation, clinical performance, and in-vivo wear of…
- Conditions
- Radiostereometric Analysis, Vitamin E Liner, Zimmer® Continuum® Acetabular Cup
- Trial name
- NCT01754155
- Testing
- RSA images
- Where
- United States
- Volunteers
- 55 people
- Sponsor
- Central DuPage Hospital
Total Hip Arthroplasty (THA)
Mpact 3D Metal Monolit Study
Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life.
- Trial name
- NCT06748885
- Testing
- Mpact 3D Metal Monolith
- Where
- 3 sites in France
- Volunteers
- 88 people
- Sponsor
- Medacta International SA
Ocular Physiology, Microcirculation
Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure.
Autoregulation is the ability of a vascular bed to maintain blood flow despite changes in perfusion pressure. For a long time it had been assumed that the choroid is a strictly passive vascular bed, which shows no autoregulation.
- Trial name
- NCT00712764
- Testing
- Adenosine
- Where
- Austria
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Medical University of Vienna
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
This phase Ib trial tests the safety, side effects and best dose of tumor membrane vesicle (TMV) vaccine therapy alone and in combination with pembrolizumab and evaluates how well it works in treating patients with head and neck…
- Conditions
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma
- Trial name
- NCT06868433
- Testing
- Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- Emory University
Wound Healing Disorder, Post-Surgical Complication
NovoX®Cup as Primary Dressing After Breast Reduction
Breast reduction is one of the most frequently performed plastic surgeries. Studies have shown that breast reduction surgery significantly improves the patients' suffering and leads to a better health-related quality of…
- Conditions
- Wound Healing Disorder, Post-Surgical Complication, Mammaplasty
- Trial name
- NCT06420323
- Testing
- Treatment with NovoX® Cup, Treatment with Omnistrip®
- Where
- Austria
- Volunteers
- 20 people
- Sponsor
- MOSS S.p.A.
Menstruation
In-use Cross-over Study of Two Different Menstrual Cups
This study evaluated the safety and tolerability of two different menstrual cups on vaginal health
- Trial name
- NCT05411796
- Testing
- Tampax menstrual cup, Other menstrual cup
- Where
- United States
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- Procter and Gamble
Total Hip Arthroplasty
Cemented Acetabular Cups Clinical Study
This clinical study has the aim to evaluate clinical, radiographic, patient-reported outcomes of total hip arthroplasty with the implant of Mueller cemented acetabular cups up to 2 years after surgery, in order to assess the…
- Trial name
- NCT04831918
- Testing
- Mueller cemented cups
- Where
- Italy
- Volunteers
- 45 people
- Sponsor
- Limacorporate S.p.a
Prosthesis Loosening
Investigating Proximal Migration in Trabecular Metal Cups Used In Acetabular Revision Surgery
This study is intended to compare the proximal migration of the tantalum design (TM) with a cemented cup used in conjunction with bone allografting in cases with major bone loss.
- Trial name
- NCT02237482
- Testing
- Trilogy cup, Trabecular metal cup (TM), ZCA cup
- Where
- Sweden
- Volunteers
- 100 people
- Sponsor
- Sahlgrenska University Hospital
Patient Satisfaction, Hip Osteoarthritis
Dual Mobility Cup: Does it Improve Patient's Satisfaction After Total Hip Arthroplastry?
Although the success of total hip arthroplasty, many patients were dissatisfied postoperatively. Patient's reported outcome measures become of a great importance in assessment of the results after joint replacement.
- Trial name
- NCT04333316
- Testing
- large head, dual mobility cup
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- Tanta University
Arthropathy of Hip, Hip Replacement
Clinical Study With the RM Pressfit Vitamys Cup in Combination With a Mathys Stem
The purpose of the study is the evaluation of the clinical and radiological short- to long-term safety and performance of the RM Pressfit vitamys cup.
- Trial name
- NCT04322916
- Testing
- RM Pressfit vitamys
- Volunteers
- 675 people
- Sponsor
- Mathys Ltd Bettlach
Neoplasms, Unknown Primary
Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
In this phase II trial, we will evaluate the feasibility and efficacy of the oxaliplatin/capecitabine combination in patients who have had one previous chemotherapy regimen for the treatment of carcinoma of unknown primary site.
- Trial name
- NCT00193609
- Testing
- Oxaliplatin, Capecitabine
- Where
- 10 sites in United States
- Volunteers
- 48 people
- Sponsor
- SCRI Development Innovations, LLC
Carcinoma of Unknown Primary
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
RATIONALE: Drugs used in chemotherapy such as gemcitabine and irinotecan use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
- Trial name
- NCT00066781
- Testing
- gemcitabine hydrochloride, irinotecan hydrochloride
- Where
- 4 sites in United States
- Volunteers
- 31 people
- Sponsor
- Alliance for Clinical Trials in Oncology